Premium
OATP1B1 and DAA treatment for hepatitis C in patients with hepatocellular carcinoma
Author(s) -
Chtioui Haithem
Publication year - 2017
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.29556
Subject(s) - daclatasvir , hepatocellular carcinoma , medicine , sofosbuvir , context (archaeology) , hepatitis c virus , hepatitis c , ledipasvir , oncology , ribavirin , virology , gastroenterology , virus , paleontology , biology